Boyd Peter E. — SEC insider filings
SEC reporting owner CIK 1739816. 19 insider filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2021-03-15 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 7,293 shares, $6,251 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 64,814 shares, $336,914 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 29,814 shares @ $4.17 ($124,414) in Aquestive Therapeutics, Inc., filed 2026-03-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | 19 | 2 legs · 7,293 sh · $6,251 | 4 legs · 64,814 sh · $336,914 | 21 |
Insider filings — Boyd Peter E.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Aquestive Therapeutics, Inc. (AQST) | Option exercise/expiry (X): 2,293 @ $0.96 · Option exercise/expiry (X): 2,293 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 56,778 @ $4.18 | EDGAR |
| 2026-04-13 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 80,000 @ $0 · Sale (S): 29,814 @ $4.17 · Grant/award (A): 42,500 (derivative) @ $4.29 | EDGAR |
| 2025-12-05 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2025-10-17 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 10,000 @ $7 | EDGAR |
| 2025-09-29 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 10,000 @ $6.30 | EDGAR |
| 2025-09-08 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 15,000 @ $5.30 | EDGAR |
| 2025-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 80,000 @ $0 · Tax withholding (F): 6,624 @ $2.65 · Tax withholding (F): 7,681 @ $2.65 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 8,370 @ $4.88 | EDGAR |
| 2024-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 86,250 @ $0 · Grant/award (A): 43,125 (derivative) @ $0 | EDGAR |
| 2023-08-09 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2022-11-08 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Aquestive Therapeutics, Inc. (AQST) | Purchase (P): 5,000 @ $0.81 | EDGAR |
| 2022-06-10 | 4 | Aquestive Therapeutics, Inc. (AQST) | Purchase (P): 2,293 @ $0.96 · Purchase (P): 2,293 (derivative) @ $0.13 | EDGAR |
| 2022-03-14 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2021-03-15 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1739816 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs